IMPLEMENT Study – Reducing vasovagal syncope and presyncope symptoms in plasma donors using applied muscle tensio

Not Applicable

Withdrawn

• Conditions: Syncope; Presyncope; Neurological - Studies of the normal brain and nervous system

• Registration Number: ACTRN12620000652976
• Lead Sponsor: Australian Red Cross Lifeblood

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-06-05
• Last Update Posted: 10 May 2021

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 13000

Inclusion Criteria

CLUSTERS
1. Donor centres with minimum attendance of 54 plasma donors per week
2. Donor centres using the Aurora machine used as standard plasmapheresis practice for a minimum of 4 weeks to 3 months depending on guidance from the Clinical Hypervigilance team and the Donor Services Leadership Team

PARTCIPANTS
1. Eligible for plasma donation as per the current ‘Guidelines for the Selection of Blood Donors’ (GSBD)
2. Plasmapheresis donation
3. Consent to participate in study (survey component only)

Exclusion Criteria

CLUSTERS
1. Plasma only donor centres
2. Donor mobile units (DMUs) and demountable mobile units
3. Participation in another research study (R&D or Marketing) that may interfere with donor recruitment and the outcomes under investigation
4. Donor Services Leadership Team consider the donor centre not appropriate for participation (e.g. centre undergoing renovations, relocation)

PARTICIPANTS
1. Donors not donating plasma by apheresis (e.g., whole blood, platelets, sample only)
2. Australian Red Cross Lifeblood staff members

Study & Design

• Study Type: Interventional
• Study Design: Not specified